Skip to content
Stop using now Drug recall · FDA · Published June 25, 2013

Apotex Recalls Latanoprost Eye Drops Due to Sterility Risk

Apotex recalls specific lots of Latanoprost Ophthalmic Solution because they may not remain sterile, posing a risk of microbial growth.

🇺🇸 FDA recall #D-852-2013DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc380 Elgin Mills Rd East · Richmond Hill, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling 50,982 bottles of Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL). The product failed the Preservative Effectiveness Test at expiry, meaning it may not prevent microbial growth before its expiration date. This recall affects bottles distributed nationwide with lot number JX1877 expiring on 06/13. Read more at govinfonow.com/recall/47403-apotex-inc-recalls-latanoprost-ophthalmic-solution-0-005-125-mcg.

Source Summary by GovInfoNow · govinfonow.com/recall/47403-apotex-inc-recalls-latanoprost-ophthalmic-solution-0-005-125-mcg · Updated October 13, 2026 · FDA enforcement record: FDA #D-852-2013

Cite this page

“Apotex Recalls Latanoprost Eye Drops Due to Sterility Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47403-apotex-inc-recalls-latanoprost-ophthalmic-solution-0-005-125-mcg. Based on FDA recall #D-852-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-852-2013%22&limit=1).

The FDA announced on June 25, 2013, that Apotex Inc. voluntarily recalled Latanoprost Ophthalmic Solution due to a lack of sterility assurance. The agency stated the product may be susceptible to microbial growth before its expiry date.

How to tell if you have it

  • Brand: Apotex
  • Product: Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL), 2.5 mL bottle
  • NDC: 60505-0565-1
  • UPC: 3 60505 05651 4
  • Lot #: JX1877, Exp 06/13

The hazard

The product failed the Preservative Effectiveness Test (PET) at expiry. According to the FDA, this failure means the ophthalmic solution may be susceptible to microbial growth before the stated expiry date.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Wal-Zan 150mg Tablets Recall (Sept. 24, 2019). Other recent recalls of similar products include Apotex Brimonidine/Timolol Eye Drops Recall (March 5, 2026), Apotex Paxil CR 37.5mg Tablets Recall (Aug. 13, 2026), and Apothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk (Sept. 24, 2026).

How to tell if you have this one

Check your eye drop bottle for the brand Apotex and the product name Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL). Look for NDC 60505-0565-1, UPC 3 60505 05651 4, and Lot # JX1877 with an expiration date of 06/13.

  • Brand
    Apotex
  • Product
    Apotex Inc recalls Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL), 2.5 mL bottle, Rx only, Manufactured by: Apotex Inc
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Jun 25, 201312. FDA classified it Class II: Aug 8, 201323. Published in FDA’s Enforcement Report: Aug 14, 201334. FDA terminated the recall: Apr 18, 2016420132016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-852-2013 (June 25, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-852-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA